SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder that’s both progressive and incurable. But now, nerve specialists ...
4f). Taken together, these data show that onapristone improves the CMT phenotype in Pmp22-transgenic rats by slowing disease progression. The rats with the highest expression of Pmp22 mRNA seemed ...
University of Pittsburgh scientists have independently validated a new blood test platform that can simultaneously measure more than a hundred biomarkers of Alzheimer's disease. The platform might ...
They have focused on the pathogenesis of inherited demyelinating neuropathies, and have developed and characterized multiple mouse models of Charcot-Marie-Tooth (CMT) neuropathies. By introducing ...
Despite an estimated 25,000 people in the UK having Charcot-Marie-Tooth disease (CMT), Becky Jones said most respond with a "glazed stare" when she tells them about her condition. CMT causes ...
The designation recognizes strengths in clinical care and research for persons with hereditary neuropathy, also known as Charcot-Marie-Tooth (CMT) disease. HNF will partner with SLU to become a hub ...
In light of those characteristics, Cellatoz is applying NRPCs, in the form of CLZ-2002, to the treatment of Charcot–Marie–Tooth (CMT) type 1A disease and other health conditions caused by ...
including the application to neurodegenerative diseases such as Charcot-Marie-Tooth disease (CMT) 1, 2. The axonal transport of intracellular vesicle and mitochondria is involved in many ...